share_log

John E. Kao Sells 500,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

John E. Kao Sells 500,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

高晓松出售50,000股Align Healthcare,Inc.(纳斯达克代码:ALHC)股票
kopsource ·  2022/08/12 19:32

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) CEO John E. Kao sold 500,000 shares of the business's stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $15.95, for a total transaction of $7,975,000.00. Following the completion of the transaction, the chief executive officer now directly owns 2,849,200 shares of the company's stock, valued at $45,444,740. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Align Healthcare,Inc.(纳斯达克代码:ALHC-GET Rating)首席执行官约翰·E·高在一笔日期为8月11日(星期四)的交易中出售了500,000股该公司股票。股票以15.95美元的平均价格出售,总成交金额为7975,000.00美元。交易完成后,首席执行官现在直接拥有该公司2,849,200股股票,价值45,444,740美元。这笔交易是在提交给美国证券交易委员会(Securities&Exchange Commission)的一份法律文件中披露的,该文件可通过以下超级链接获得。

Alignment Healthcare Trading Up 2.4 %

Align Healthcare交易上涨2.4%

NASDAQ ALHC traded up $0.38 during trading on Friday, reaching $16.48. 623,524 shares of the stock traded hands, compared to its average volume of 607,744. The firm has a market cap of $3.09 billion, a price-to-earnings ratio of -20.06 and a beta of 2.05. The stock's 50-day moving average price is $13.28 and its 200 day moving average price is $10.81. The company has a quick ratio of 2.74, a current ratio of 2.74 and a debt-to-equity ratio of 0.52. Alignment Healthcare, Inc. has a fifty-two week low of $6.14 and a fifty-two week high of $23.35.

纳斯达克ALHC在周五的交易中上涨了0.38美元,达到16.48美元。该股共有623,524股易手,而其平均成交量为607,744股。该公司的市值为30.9亿美元,市盈率为-20.06倍,贝塔系数为2.05。该股的50日移动均线价格为13.28美元,200日移动均线价格为10.81美元。该公司的速动比率为2.74,流动比率为2.74,债务权益比率为0.52。Align Healthcare,Inc.的股价为6.14美元,为52周低点,52周高点为23.35美元。

Get
到达
Alignment Healthcare
调整医疗保健
alerts:
警报:

Alignment Healthcare (NASDAQ:ALHC – Get Rating) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.20. Alignment Healthcare had a negative net margin of 11.20% and a negative return on equity of 47.96%. During the same period in the previous year, the firm earned ($0.25) earnings per share. Analysts predict that Alignment Healthcare, Inc. will post -0.81 EPS for the current year.

Align Healthcare(纳斯达克:ALHC-GET Rating)最近一次发布季度收益报告是在8月4日(星期四)。该公司公布本季度每股收益(0.06美元),比普遍预期的(0.26美元)高出0.20美元。Align Healthcare的净利润率为负11.20%,股本回报率为负47.96%。去年同期,该公司每股收益为0.25美元。分析师预测,Align Healthcare,Inc.将公布本年度每股收益为0.81美元。

Analyst Upgrades and Downgrades

分析师升级和下调评级

Several equities research analysts have recently commented on ALHC shares. Morgan Stanley lifted their price target on shares of Alignment Healthcare from $18.00 to $19.00 and gave the stock an "overweight" rating in a research report on Wednesday. The Goldman Sachs Group lifted their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock a "buy" rating in a research report on Monday. Piper Sandler lifted their price target on shares of Alignment Healthcare from $15.00 to $20.00 and gave the stock an "overweight" rating in a research report on Friday, August 5th. William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a research report on Thursday, May 5th. Finally, Barclays lifted their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a research report on Monday. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $18.20.
几位股票研究分析师最近对ALHC的股票发表了评论。周三,摩根士丹利在一份研究报告中将Align Healthcare的目标价从18.00美元上调至19.00美元,并给予该股“增持”评级。高盛夫妇在周一的一份研究报告中将Align Healthcare的目标价从14.00美元上调至21.00美元,并给予该股“买入”评级。派珀·桑德勒在8月5日星期五的一份研究报告中将Align Healthcare的目标价从15.00美元上调至20.00美元,并给予该股“增持”评级。威廉·布莱尔在5月5日(星期四)的一份研究报告中重申了对Align Healthcare股票的“跑赢大盘”评级。最后,巴克莱将Align Healthcare的目标价从14.00美元上调至21.00美元,并在周一的一份研究报告中给予该股“增持”评级。一名投资分析师对该股的评级为持有,10名分析师对该股的评级为买入。根据MarketBeat的数据,该股目前的平均评级为“适度买入”,共识目标价为18.20美元。

Institutional Inflows and Outflows

机构资金流入和流出

Several institutional investors and hedge funds have recently made changes to their positions in ALHC. Nisa Investment Advisors LLC acquired a new position in shares of Alignment Healthcare in the first quarter valued at approximately $34,000. First Quadrant LLC CA acquired a new position in shares of Alignment Healthcare in the first quarter valued at approximately $47,000. US Bancorp DE lifted its position in shares of Alignment Healthcare by 15.8% in the second quarter. US Bancorp DE now owns 6,704 shares of the company's stock worth $76,000 after purchasing an additional 914 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Alignment Healthcare by 10.4% in the first quarter. Victory Capital Management Inc. now owns 11,124 shares of the company's stock worth $107,000 after purchasing an additional 1,045 shares in the last quarter. Finally, Ieq Capital LLC bought a new stake in shares of Alignment Healthcare in the first quarter worth $112,000. Institutional investors and hedge funds own 82.68% of the company's stock.

几家机构投资者和对冲基金最近改变了他们在ALHC的头寸。NISA Investment Advisors LLC在第一季度收购了Align Healthcare的新头寸,价值约3.4万美元。第一跨骏有限责任公司在第一季度收购了Align Healthcare的新股份,价值约为4.7万美元。US Bancorp DE在第二季度将其在Align Healthcare的股票头寸提高了15.8%。US Bancorp DE现在拥有该公司6704股股票,价值7.6万美元,此前在上个季度又购买了914股。第一季度,胜利资本管理公司将其在Align Healthcare的持股比例提高了10.4%。胜利资本管理公司现在持有11,124股该公司股票,价值10.7万美元,该公司在上个季度又购买了1,045股。最后,IEQ Capital LLC在第一季度购买了Align Healthcare价值11.2万美元的新股。机构投资者和对冲基金持有该公司82.68%的股票。

About Alignment Healthcare

关于Align Healthcare

(Get Rating)

(获取评级)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.

Align Healthcare,Inc.是一家技术支持的Medicare Advantage公司,运营着以消费者为中心的医疗保健平台。它通过其Medicare Advantage计划在美国为老年人和那些需要它的人提供定制的医疗保健。该公司在加利福尼亚州、北卡罗来纳州和内华达州拥有Medicare Advantage计划。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Alignment Healthcare (ALHC)
  • What Is WallStreetBets and What Stocks Are They Targeting?
  • Institutions And Analysts Propel Jack In The Box Higher
  • Can You Guess Which EV Stock Is Beating Tesla ?
  • Look at Honeywell for a Steady and Diversified Stock
  • Why Invest in High-Yield Dividend Stocks?
  • 免费获取StockNews.com关于Align Healthcare(ALHC)的研究报告
  • 什么是WallStreetBets,他们的目标是什么股票?
  • 机构和分析师推动Jack in the Box走高
  • 你能猜到哪个电动车股票打败了特斯拉吗?
  • 霍尼韦尔看好稳定和多元化的股票
  • 为什么要投资高收益股利股票?

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

接收Align Healthcare Daily的新闻和评级-在下面输入您的电子邮件地址,以便通过MarketBeat.com的免费每日电子邮件时事通讯接收对Align Healthcare和相关公司的最新新闻和分析师评级的简要每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发